224 related articles for article (PubMed ID: 12790326)
1. Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.
Kopp R; Rothbauer E; Ruge M; Arnholdt H; Spranger J; Muders M; Pfeiffer DG; Schildberg FW; Pfeiffer A
Recent Results Cancer Res; 2003; 162():115-32. PubMed ID: 12790326
[TBL] [Abstract][Full Text] [Related]
2. Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients.
Kopp R; Ruge M; Rothbauer E; Cramer C; Kraemling HJ; Wiebeck B; Schildberg FW; Pfeiffer A
Anticancer Res; 2002; 22(2B):1161-7. PubMed ID: 12168918
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of epidermal growth factor receptor and mRNA of its ligands in Helicobacter pylori-infected gastric mucosa.
Schiemann U; Konturek JW; Osterhoff M; Assert R; Rembiasz K; Pfeiffer D; Schatz H; Domschke W; Pfeiffer A
Scand J Gastroenterol; 2001 Jan; 36(1):23-31. PubMed ID: 11218236
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-erbB receptors and ligands in human bronchial mucosa.
Polosa R; Prosperini G; Leir SH; Holgate ST; Lackie PM; Davies DE
Am J Respir Cell Mol Biol; 1999 May; 20(5):914-23. PubMed ID: 10226061
[TBL] [Abstract][Full Text] [Related]
5. Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels.
Kopp R; Rothbauer E; Mueller E; Schildberg FW; Jauch KW; Pfeiffer A
Dis Colon Rectum; 2003 Oct; 46(10):1391-9. PubMed ID: 14530681
[TBL] [Abstract][Full Text] [Related]
6. Growth factors and oncogenes in human gastrointestinal carcinomas.
Tahara E
J Cancer Res Clin Oncol; 1990; 116(2):121-31. PubMed ID: 2157713
[TBL] [Abstract][Full Text] [Related]
7. Involvement of epidermal growth factor receptor in chemically induced mouse bladder tumour progression.
el-Marjou A; Delouvée A; Thiery JP; Radvanyi F
Carcinogenesis; 2000 Dec; 21(12):2211-8. PubMed ID: 11133810
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H
Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575
[TBL] [Abstract][Full Text] [Related]
9. The ErbB/HER family of protein-tyrosine kinases and cancer.
Roskoski R
Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
[TBL] [Abstract][Full Text] [Related]
10. Ligand-Independent Epidermal Growth Factor Receptor Overexpression Correlates with Poor Prognosis in Colorectal Cancer.
Yun S; Kwak Y; Nam SK; Seo AN; Oh HK; Kim DW; Kang SB; Lee HS
Cancer Res Treat; 2018 Oct; 50(4):1351-1361. PubMed ID: 29361822
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
12. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
Sørensen BS; Tørring N; Bor MV; Nexø E
Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells.
Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y
Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719
[TBL] [Abstract][Full Text] [Related]
14. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
15. Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium.
Imai T; Kurachi H; Adachi K; Adachi H; Yoshimoto Y; Homma H; Tadokoro C; Takeda S; Yamaguchi M; Sakata M
Biol Reprod; 1995 Apr; 52(4):928-38. PubMed ID: 7540053
[TBL] [Abstract][Full Text] [Related]
16. Expression of several growth factors and their receptor genes in human colon carcinomas.
Ito M; Yoshida K; Kyo E; Ayhan A; Nakayama H; Yasui W; Ito H; Tahara E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(3):173-8. PubMed ID: 1980764
[TBL] [Abstract][Full Text] [Related]
17. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA
Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194
[TBL] [Abstract][Full Text] [Related]
18. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate.
Adam RM; Borer JG; Williams J; Eastham JA; Loughlin KR; Freeman MR
Endocrinology; 1999 Dec; 140(12):5866-75. PubMed ID: 10579352
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated expression of ADAM17 in gastrointestinal stromal tumors: coexpression with EGFR and EGFR ligands.
Nakagawa M; Nabeshima K; Asano S; Hamasaki M; Uesugi N; Tani H; Yamashita Y; Iwasaki H
Cancer Sci; 2009 Apr; 100(4):654-62. PubMed ID: 19298600
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
